Does PALBOCICLIB Cause C-reactive protein increased? 99 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 99 reports of C-reactive protein increased have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
99
Reports of C-reactive protein increased with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
28
Deaths
80
Hospitalizations
How Dangerous Is C-reactive protein increased From PALBOCICLIB?
Of the 99 reports, 28 (28.3%) resulted in death, 80 (80.8%) required hospitalization, and 38 (38.4%) were considered life-threatening.
Is C-reactive protein increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 99 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause C-reactive protein increased?
METHOTREXATE (5,999)
ADALIMUMAB (4,579)
RITUXIMAB (4,060)
ETANERCEPT (3,922)
TOCILIZUMAB (3,719)
INFLIXIMAB (3,621)
LEFLUNOMIDE (3,574)
HYDROXYCHLOROQUINE (3,552)
ABATACEPT (3,451)
SULFASALAZINE (3,096)
Which PALBOCICLIB Alternatives Have Lower C-reactive protein increased Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID